Inventor
Edward H. Ruediger
Inventor
Greenfield Park, CA
Overview
Patents· 49 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds30%
A61KPreparations for medical, dental or toiletry purposes18%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium6%
C07HSugars4%
C07BGeneral methods of organic chemistry3%
Y02PClimate change mitigation technologies in the production or processing of goods3%
C07KPeptides2%
Y02ATechnologies for adaptation to climate change2%
PatentTitleYear
10,822,343Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregation202010,428,077Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregation201910,238,638Benzothiazole and benzothiophene compounds201910,047,103Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation20189,862,730'Imidazothiadiazole derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation'20189,758,487'Hepatitis C virus inhibitors'20179,688,695'Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation'20179,655,888'Tricyclic alkene derivatives as HIV attachment inhibitors'20179,505,752'Piperidine amide derivatives as HIV attachment inhibitors'20169,227,961'Hepatitis C virus inhibitors'20169,018,390'Hepatitis C virus inhibitors'20158,846,023'Hepatitis C virus inhibitors'20148,642,025'Hepatitis C virus inhibitors'20148,574,563'Hepatitis C virus inhibitors'20138,492,553'Hepatitis C virus inhibitors'20138,303,944'Hepatitis C virus inhibitors'20128,288,562'Hepatitis C virus inhibitors'20128,211,928'Hepatitis C virus inhibitors'20128,147,818'Hepatitis C virus inhibitors'20128,143,414'Hepatitis C virus inhibitors'20128,093,243'Hepatitis C virus inhibitors'20127,915,283'Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides'20117,759,495'Hepatitis C virus inhibitors'20107,745,636'Hepatitis C virus inhibitors'20107,741,347'Hepatitis C virus inhibitors'20107,704,992'Hepatitis C virus inhibitors'20107,659,270'Hepatitis C virus inhibitors'20107,501,419'4-Squarylpiperazine derivatives as antiviral agents'20097,449,476'Tetrahydrocarboline antiviral agents'20087,396,830'Piperazine amidines as antiviral agents'20087,348,337'Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides'20087,138,377'Topoisomerase inhibitors'20067,102,003'Pyrrolotriazine compounds'20067,067,525'Compounds useful as modulators of Melanocortin Receptors and pharmaceutical compositions comprising same'20067,064,203'Di-substituted pyrrolotriazine compounds'20066,979,691'Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same'20056,855,698'Topoisomerase I selective cytotoxic sugar derivatives of indolopyrrolocarbazoles'20056,713,487'Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same'20046,686,385'Anhydro sugar derivatives of indolocarbazoles'20046,677,450'Topoisomerase inhibitors'20046,653,290'Tumor proliferation inhibitors'20036,610,727'Anhydro sugar derivatives of indolocarbazoles'20036,534,507'Methods for treating psychological disorders using bioactive metabolites of gepirone'20035,618,816'Antimigraine 1,2,5-thiadiazole derivatives of indolylalkyl-pyridnyl and pyrimidinylpiperazines'19975,521,188'Antimigraine cyclobutenedione derivatives of indolylalkyl-pyridinyl and pyrimidinylpiperazines'19965,434,154'Antimigraine 4-pyrimidinyl and pyridinyl derivatives of indol-3yl-alkylpiperazines'19955,382,592'Antimigraine cyclobutenedione derivatives of tryptamines'19955,300,506'Indolylalkyl derivatives of pyrimidinylpiperazine for treating vascular headache'19944,956,368'Metabolites and prodrug formulations of 8-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]-8-azaspiro[4.5]de cane-7,9-dione'1990Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1990–2020Based in Greenfield Park, CA· patent location history
1994–2020Patents assigned to BRISTOL MYERS SQUIBB CO (46)· patent assignee history
1995–2006Based in Quebec, CA· patent location history
2003Based in Sherwood Park, CA· patent location history
2012–2013Patents assigned to LAVOIE RICO (8)· patent assignee history
2012–2013Patents assigned to RUEDIGER EDWARD H (8)· patent assignee history
2012–2013Patents assigned to BACHAND CAROL (7)· patent assignee history
2012–2013Patents assigned to JAMES CLINT A (7)· patent assignee history
2019Based in Montreal, CA· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BRISTOL MYERS SQUIBB CO | 46 | 1994–2020 |
| LAVOIE RICO | 8 | 2012–2013 |
| RUEDIGER EDWARD Hself | 8 | 2012–2013 |
| BACHAND CAROL | 7 | 2012–2013 |
| JAMES CLINT A | 7 | 2012–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Greenfield Park, CA | 41 | 1990–2020 |
| Quebec, CA | 6 | 1995–2006 |
| Montreal, CA | 1 | 2019 |
| Sherwood Park, CA | 1 | 2003 |